Diagnostic Technology Pty

Diagnostic Technology is a leading supplier of innovative clinical diagnostics and life science products in the Australian and New Zealand markets. The company’s clinical product portfolio includes molecular testing systems for infectious pathogen detection, molecular controls and standards, as well as probe hybridization (FISH) technology for cancer and genomic applications, and digital pathology management systems. In the life sciences field, the company represents many cutting-edge technologies, focusing on single-cell isolation/retrieval for downstream applications such as next-generation sequencing, electroporation/transfection of mammalian cells for cell therapy, protein production, genomics, and a range of products for the storage, purification, and preservation of nucleic acid materials. Locally, the company has developed a series of unique molecular testing kits to identify and quantify the presence of toxin-producing cyanobacteria and dinoflagellates in environmental samples. These products, named Phytoxigene, are being used worldwide to help monitor the presence of harmful algal blooms (HABs) in water systems.